跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARX MORPHINE MR morphine sulfate pentahydrate 30 mg modified release tablet blister packs - TGA Drug Approval Details
Approvals
/
TGA
/
ARX MORPHINE MR morphine sulfate pentahydrate 30 mg modified release tablet blister packs
Approved
STANDARD
ARX MORPHINE MR morphine sulfate pentahydrate 30 mg modified release tablet blister packs
Southern Cross Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
08172d89346856a5
Company
Southern Cross Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
08172d89346856a5
Product Name
ARX MORPHINE MR morphine sulfate pentahydrate 30 mg modified release tablet blister packs
Artg Id
132254
Artg Name
ARX MORPHINE MR morphine sulfate pentahydrate 30 mg modified release tablet blister packs
Sponsor
Southern Cross Pharma Pty Ltd
Company Detail Path
/organization/southern-cross-pharma-pty-ltd
Artg Date
2009-04-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/d0c71569a33790b41f900ff2f9620145.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/fced89ce6de1932e1c29935991aeb5ef.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
08172d89346856a5
Type
Standard
Back to TGA Approvals